CVRx, Inc. (NasdaqGS: CVRX)
Health Care · Health Care Equipment & Supplies · US
$3.37
+6.98% today · -54.8% 1Y
CVRx, Inc. (NasdaqGS: CVRX) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $89.78M and employs 223 people.
Over the last twelve months the share price has lost 54.8%, trading between 2.20 and 11.30.
Tweenvest scores CVRx, Inc. across four factors: quality 30/100, value 51/100, growth 100/100. Its strongest factor is growth.
CVRX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $89.78M
- Revenue (TTM)
- $61.19M
- P/E
- —
- EPS
- -1.97
- Dividend yield
- —
- Beta (5Y)
- 0.82
- 52-week high
- $11.30
- 52-week low
- $2.20
- Avg volume (3M)
- —
- Shares outstanding
- 26.64M
- Employees
- 223
- Next earnings
- —
About CVRx, Inc.
CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases. Its principal offering, Barostim, is an advanced neuromodulation device specifically indicated to ameliorate symptoms for patients diagnosed with heart failure characterized by reduced ejection fraction, often referred to as systolic heart failure. The company employs a diverse distribution strategy, leveraging its internal sales force, alongside sales agents and independent distributors, to reach markets across the United States, Germany, the wider European continent, and other global territories. Incorporated in 2000, CVRx, Inc. is headquartered in Minneapolis, Minnesota.
- ISIN
- US1266381052
- Founded
- 2000
- Listed since
- Jun 30, 2021
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $116.13 | 0.00% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $372.62 | +0.21% |
| Stryker CorporationNYSE: SYK | $126.81B | $331.82 | +0.37% |
| Medtronic plcNYSE: MDT | $116.66B | $91.10 | -0.04% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €160.15 | +0.63% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $47.90 | -3.93% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $90.87 | +0.41% |
Figures last refreshed Aug 18, 2026.